Effect of an Inhibitor of Nitric Oxide Production on Cu-Zn/SOD and Its Cofactors in Diabetic Rats


    loading  Checking for direct PDF access through Ovid

Abstract

The aim of this study was to investigate the effect of an inhibitor of nitric oxide production, Nω-nitro-L-arginine methyl esther (L-NAME) on Cu-Zn/SOD (superoxide dismutase) enzyme activity and copper and zinc concentrations in diabetes-induced rats. The control group consisted of 12 male albino Sprague–Dawley rats, 10–12 wk of age and weighing 300 g. Twenty-six albino Sprague–Dawley rats, 10–12 wk of age and weighing 315 g, constituted the experimental group. The experimental group was divided into two groups. The first group (n=12) constituted streptozotocin-induced (55 mg/kg, intraperitoneally) diabetic rats and the second group (n=14) was administered L-NAME (1 mg/kg/d) after streptozotocin induction. For determination of Cu-Zn/SOD activity, spectrophotometry was used. Zinc and copper concentrations were determined by atomic absorption spectrophotometry.Results showed that Cu-Zn/SOD activity was increased significantly in both experimental groups compared to controls, and the increase in the second group was higher than in the first group (p <0.01, p <0.01, p <0.05). Plazma zinc concentration was increased in the second group when com-pared with controls (p <0.05). Plasma copper was decreased significantly in the second group compared to controls and the first group (p <0.001, p <0.001). Red cell copper concentration was decreased significantly in the first group compared to controls (p <0.05). This study showed that L-NAME administration has ensured an additive effect on the antioxidant defense system, which was proved by the increase in Cu-Zn/SOD activity. This increase might have a protective effect against tissue damage in the acute period, with corresponding changes in zinc and copper concentrations.

    loading  Loading Related Articles